8:22 AM
May 09, 2018
 |  BC Innovations  |  Distillery Therapeutics


INDICATION: Breast cancer

Patient sample and cell culture studies suggest inhibiting BARD1, BRCA1, CDK1 or CKD12 could help treat tamoxifen-resistant breast cancer. In tumor tissue from 27 recurrent breast cancer patients whose tumors became resistant to tamoxifen, BARD1 and BRCA1 expression was higher...

Read the full 195 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Innovations

Article Purchase

$35 USD
More Info >